By Iain Gilbert
Date: Friday 13 Feb 2026
(Sharecast News) - Life science business SkinBioTherapeutics said on Friday that chief executive Stuart Ashman has resigned, having been suspended by the board pending an investigation into matters relating to his conduct.
SkinBioTherapeutics said it was undertaking a full investigation, supported by its professional advisors.
Martin Hunt, non-executive chairman of...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news